252 related articles for article (PubMed ID: 33792440)
1. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
Climacteric; 2021 Dec; 24(6):533-550. PubMed ID: 33792440
[TBL] [Abstract][Full Text] [Related]
2. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Sex Med; 2021 May; 18(5):849-867. PubMed ID: 33814355
[TBL] [Abstract][Full Text] [Related]
3. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Womens Health (Larchmt); 2021 Apr; 30(4):474-491. PubMed ID: 33797277
[No Abstract] [Full Text] [Related]
4. The International Society for the Study of Women's Sexual Health Process of Care for Management of Hypoactive Sexual Desire Disorder in Women.
Clayton AH; Goldstein I; Kim NN; Althof SE; Faubion SS; Faught BM; Parish SJ; Simon JA; Vignozzi L; Christiansen K; Davis SR; Freedman MA; Kingsberg SA; Kirana PS; Larkin L; McCabe M; Sadovsky R
Mayo Clin Proc; 2018 Apr; 93(4):467-487. PubMed ID: 29545008
[TBL] [Abstract][Full Text] [Related]
5. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
6. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Kingsberg SA; Simon JA; Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
[TBL] [Abstract][Full Text] [Related]
7. Hypoactive Sexual Desire Disorder: International Society for the Study of Women's Sexual Health (ISSWSH) Expert Consensus Panel Review.
Goldstein I; Kim NN; Clayton AH; DeRogatis LR; Giraldi A; Parish SJ; Pfaus J; Simon JA; Kingsberg SA; Meston C; Stahl SM; Wallen K; Worsley R
Mayo Clin Proc; 2017 Jan; 92(1):114-128. PubMed ID: 27916394
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Davis SR; Braunstein GD
J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder-a claims database analysis.
Agrawal P; Lee YS; Grutman AJ; Dumas K; Kohn T; Kohn J; Yee AM; Clifton M
J Sex Med; 2024 Mar; 21(4):288-293. PubMed ID: 38441520
[TBL] [Abstract][Full Text] [Related]
10. Testosterone use for hypoactive sexual desire disorder in postmenopausal women.
Parish SJ; Kling JM
Menopause; 2023 Jul; 30(7):781-783. PubMed ID: 37314872
[TBL] [Abstract][Full Text] [Related]
11. Approved hormonal treatments for HSDD: an unmet medical need.
Snabes MC; Simes SM
J Sex Med; 2009 Jul; 6(7):1846-9. PubMed ID: 19453872
[TBL] [Abstract][Full Text] [Related]
12. Systemic testosterone for the treatment of female sexual interest and arousal disorder (FSIAD) in the postmenopause.
Ribera Torres L; Anglès-Acedo S; López Chardi L; Mension Coll E; Castelo-Branco C
Gynecol Endocrinol; 2024 Dec; 40(1):2364220. PubMed ID: 38913119
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy of Hypoactive Sexual Desire Disorder in Premenopausal Women.
Barakeh D; Mdaihly H; Karaoui LR
Ann Pharmacother; 2024 May; ():10600280241253273. PubMed ID: 38767282
[TBL] [Abstract][Full Text] [Related]
14. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
15. Testosterone supplementation for hypoactive sexual desire disorder in women.
Woodis CB; McLendon AN; Muzyk AJ
Pharmacotherapy; 2012 Jan; 32(1):38-53. PubMed ID: 22392827
[TBL] [Abstract][Full Text] [Related]
16. Methodological Challenges in Studying Testosterone Therapies for Hypoactive Sexual Desire Disorder in Women.
Rowen TS; Davis SR; Parish S; Simon J; Vignozzi L
J Sex Med; 2020 Apr; 17(4):585-594. PubMed ID: 32063470
[TBL] [Abstract][Full Text] [Related]
17. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
18. Management of hypoactive sexual desire disorder in transgender women: a guide for clinicians.
Cocchetti C; Ristori J; Mazzoli F; Vignozzi L; Maggi M; Fisher AD
Int J Impot Res; 2020 Nov; 33(7):703-709. PubMed ID: 33558671
[TBL] [Abstract][Full Text] [Related]
19. The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review.
Uloko M; Rahman F; Puri LI; Rubin RS
Int J Impot Res; 2022 Nov; 34(7):635-641. PubMed ID: 36198811
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
